Literature DB >> 154845

Hypertrophic cardiomyopathy in the dog.

S K Liu, B J Maron, L P Tilley.   

Abstract

Clinical and necropsy findings in 10 dogs with a spontaneous primary hypertrophic cardiomyopathy are described. Each dog had marked cardiac hypertrophy, and 8 dogs had disproportionate thickening of the ventricular septum with respect to the left ventricular free wall (compared with dogs with normal hearts or with cardiac hypertrophy due to acquired or congenital heart disease). Septal:free wall thickness ratios in the 10 dogs ranged from 1.1 to 1.5; 6 had ratios greater than or equal to 1.3. However, marked cardiac muscle cell disorganization in the ventricular septum, characteristic of patients with hypertrophic cardiomyopathy, was present in only 2 of the 10 dogs. Death occurred most commonly while the dogs were under anesthesia during the course of operative procedures (5 dogs) or suddenly and unexpectedly in animals without previous symptomatic manifestations of cardiac disease (3 dogs). Four dogs had clinical signs of congestive heart failure, including 2 with marked cardiac decompensation. In addition, 2 of these 4 dogs with heart failure and 1 dog without previous symptoms (that died during a noncardiac operation) manifested complete heart block. It is conceivable that dogs with spontaneous hypertrophic cardiomyopathy may prove useful in the future investigations of the clinical, hemodynamic, and pathologic features of this disease in humans.

Entities:  

Mesh:

Year:  1979        PMID: 154845      PMCID: PMC2042261     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  16 in total

1.  ANATOMY OF THE A-V NODE OF THE DOG.

Authors:  T N JAMES
Journal:  Anat Rec       Date:  1964-01

2.  Asymmetrical hypertrophy of the heart in young adults.

Authors:  D TEARE
Journal:  Br Heart J       Date:  1958-01

3.  The clinical, hemodynamic, and pathologic diagnosis of muscular subvalvular aortic stenosis.

Authors:  H MENGES; R O BRANDENBURG; A L BROWN
Journal:  Circulation       Date:  1961-11       Impact factor: 29.690

4.  Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. A study of operatively excised left ventricular outflow tract muscle in 14 patients.

Authors:  V J Ferrans; A G Morrow; W C Roberts
Journal:  Circulation       Date:  1972-04       Impact factor: 29.690

5.  Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings.

Authors:  B J Maron; V J Ferrans; W L Henry; C E Clark; D R Redwood; W C Roberts; A G Morrow; S E Epstein
Journal:  Circulation       Date:  1974-09       Impact factor: 29.690

Review 6.  Valvular, subvalvular and supravalvular aortic stenosis: morphologic features.

Authors:  W C Roberts
Journal:  Cardiovasc Clin       Date:  1973

7.  The clinical course in muscular subaortic stenosis. A retrospective and prospective study of 60 hemodynamically proved cases.

Authors:  A G Adelman; E D Wigle; N Ranganathan; G D Webb; B S Kidd; W G Bigelow; M D Silver
Journal:  Ann Intern Med       Date:  1972-10       Impact factor: 25.391

8.  Left ventricular hypertrophy diagnosed by echocardiography.

Authors:  A S Abbasi; R N MacAlpin; L M Eber; M L Pearce
Journal:  N Engl J Med       Date:  1973-07-19       Impact factor: 91.245

9.  Malformation of the canine mitral valve complex.

Authors:  S K Litu; L P Tilley
Journal:  J Am Vet Med Assoc       Date:  1975-09-15       Impact factor: 1.936

10.  Dysplasia of the tricuspid valve in the dog and cat.

Authors:  S K Liu; L P Tilley
Journal:  J Am Vet Med Assoc       Date:  1976-09-15       Impact factor: 1.936

View more
  10 in total

Review 1.  Myocardial disarray. A critical review.

Authors:  A E Becker; G Caruso
Journal:  Br Heart J       Date:  1982-06

Review 2.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

3.  Histological and ultrastructural evaluation of cardiac lesions in idiopathic cardiomyopathy in dogs.

Authors:  G E Sandusky; C C Capen; K M Kerr
Journal:  Can J Comp Med       Date:  1984-01

4.  MYBPC3 Haplotype Linked to Hypertrophic Cardiomyopathy in Rhesus Macaques (Macaca mulatta).

Authors:  Robert F Oldt; Kimberly J Bussey; Matthew L Settles; Joseph N Fass; Jeffrey A Roberts; J Rachel Reader; Srivathsan Komandoor; Victor A Abrich; Sreetharan Kanthaswamy
Journal:  Comp Med       Date:  2020-08-04       Impact factor: 0.982

5.  A retrospective study of heart disease in doberman pinscher dogs.

Authors:  M J Hazlett; M G Maxie; D G Allen; B P Wilcock
Journal:  Can Vet J       Date:  1983-07       Impact factor: 1.008

Review 6.  A One Health Approach to Hypertrophic Cardiomyopathy.

Authors:  Yu Ueda; Joshua A Stern
Journal:  Yale J Biol Med       Date:  2017-09-25

Review 7.  Bacterial Cellulose and ECM Hydrogels: An Innovative Approach for Cardiovascular Regenerative Medicine.

Authors:  Izabela Gabriela Rodrigues da Silva; Bruna Tássia Dos Santos Pantoja; Gustavo Henrique Doná Rodrigues Almeida; Ana Claudia Oliveira Carreira; Maria Angélica Miglino
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

Review 8.  Animal models of primary myocardial diseases.

Authors:  S K Liu; L P Tilley
Journal:  Yale J Biol Med       Date:  1980 May-Jun

Review 9.  Spontaneously occurring cardiovascular lesions in commonly used laboratory animals.

Authors:  Eugene Herman; Sandy Eldridge
Journal:  Cardiooncology       Date:  2019-06-03

10.  Retrospective evaluation of hypertrophic cardiomyopathy in 68 dogs.

Authors:  Karsten E Schober; Phillip R Fox; Jonathan Abbott; Etienne Côté; Virginia Luis-Fuentes; Jose Novo Matos; Joshua A Stern; Lance Visser; Katherine F Scollan; Valerie Chetboul; Donald Schrope; Tony Glaus; Roberto Santilli; Romain Pariaut; Rebecca Stepien; Vanessa Arqued-Soubeyran; Marco Baron Toaldo; Amara Estrada; Kristin MacDonald; Emily T Karlin; John Rush
Journal:  J Vet Intern Med       Date:  2022-03-24       Impact factor: 3.175

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.